134 related articles for article (PubMed ID: 2783975)
21. Monoclonal antibody drug conjugates for site-directed cancer chemotherapy: preclinical pharmacology and toxicology studies.
Johnson IS; Spearman ME; Todd GC; Zimmerman JL; Bumol TF
Cancer Treat Rev; 1987 Dec; 14(3-4):193-6. PubMed ID: 3501969
[No Abstract] [Full Text] [Related]
22. Vinblastine-C4 alkyl maleoyl and amino acid maleoyl derivatives: III. Experimental antitumor activities of lactosaminated serum albumin conjugates.
Rao KS; Collard MP; Cornet J; Trouet A
Anticancer Res; 1989; 9(4):973-9. PubMed ID: 2510584
[TBL] [Abstract][Full Text] [Related]
23. Targeted cancer therapy: conferring specificity to cytotoxic drugs.
Chari RV
Acc Chem Res; 2008 Jan; 41(1):98-107. PubMed ID: 17705444
[TBL] [Abstract][Full Text] [Related]
24. Folate-vinca alkaloid conjugates for cancer therapy: a structure-activity relationship.
Leamon CP; Vlahov IR; Reddy JA; Vetzel M; Santhapuram HK; You F; Bloomfield A; Dorton R; Nelson M; Kleindl P; Vaughn JF; Westrick E
Bioconjug Chem; 2014 Mar; 25(3):560-8. PubMed ID: 24564229
[TBL] [Abstract][Full Text] [Related]
25. In vivo studies of whole ricin monoclonal antibody immunoconjugates for the treatment of murine tumours.
Kanellos J; MacKenzie IF; Pietersz GA
Immunol Cell Biol; 1988; 66 ( Pt 5-6)():403-15. PubMed ID: 3265693
[TBL] [Abstract][Full Text] [Related]
26. Preparation and characterization of monoclonal antibody conjugates of the calicheamicins: a novel and potent family of antitumor antibiotics.
Hinman LM; Hamann PR; Wallace R; Menendez AT; Durr FE; Upeslacis J
Cancer Res; 1993 Jul; 53(14):3336-42. PubMed ID: 8324745
[TBL] [Abstract][Full Text] [Related]
27. Synthesis of site-specific methotrexate-IgG conjugates. Comparison of stability and antitumor activity with active-ester-based conjugates.
Kralovec J; Singh M; Mammen M; Blair AH; Ghose T
Cancer Immunol Immunother; 1989; 29(4):293-302. PubMed ID: 2787696
[TBL] [Abstract][Full Text] [Related]
28. Solution stability of the monoclonal antibody-vinca alkaloid conjugate, KS1/4-DAVLB.
Riggin A; Clodfelter D; Maloney A; Rickard E; Massey E
Pharm Res; 1991 Oct; 8(10):1264-9. PubMed ID: 1796044
[TBL] [Abstract][Full Text] [Related]
29. Antitumor properties of vindesine-monoclonal antibody conjugates.
Rowland GF; Axton CA; Baldwin RW; Brown JP; Corvalan JR; Embleton MJ; Gore VA; Hellström I; Hellström KE; Jacobs E
Cancer Immunol Immunother; 1985; 19(1):1-7. PubMed ID: 3844970
[TBL] [Abstract][Full Text] [Related]
30. A carbohydrate-directed heterobifunctional cross-linking reagent for the synthesis of immunoconjugates.
Zara JJ; Wood RD; Boon P; Kim CH; Pomato N; Bredehorst R; Vogel CW
Anal Biochem; 1991 Apr; 194(1):156-62. PubMed ID: 1867379
[TBL] [Abstract][Full Text] [Related]
31. Antigen-specific activity of carcinoma-reactive BR64-doxorubicin conjugates evaluated in vitro and in human tumor xenograft models.
Trail PA; Willner D; Lasch SJ; Henderson AJ; Greenfield RS; King D; Zoeckler ME; Braslawsky GR
Cancer Res; 1992 Oct; 52(20):5693-700. PubMed ID: 1382845
[TBL] [Abstract][Full Text] [Related]
32. Immunochemotherapy of human colon carcinoma xenografts in nude mice using combinations of idarubicin-monoclonal antibody conjugates.
Smyth MJ; Foster HM; Andrew SM; Teh JG; Krauer K; McKenzie IF; Pietersz GA
Immunol Cell Biol; 1993 Jun; 71 ( Pt 3)():167-79. PubMed ID: 8349300
[TBL] [Abstract][Full Text] [Related]
33. Antitumor activity of doxorubicin-monoclonal antibody conjugate on human bladder cancer.
Yu DS; Chu TM; Yeh MY; Chang SY; Ma CP; Han SH
J Urol; 1988 Aug; 140(2):415-21. PubMed ID: 3398165
[TBL] [Abstract][Full Text] [Related]
34. Increased antitumor effect of immunoconjugates and tumor necrosis factor in vivo.
Smyth MJ; Pietersz GA; McKenzie IF
Cancer Res; 1988 Jul; 48(13):3607-12. PubMed ID: 3259905
[TBL] [Abstract][Full Text] [Related]
35. Synthesis of methotrexate-antibody conjugates by regiospecific coupling and assessment of drug and antitumor activities.
Kralovec J; Spencer G; Blair AH; Mammen M; Singh M; Ghose T
J Med Chem; 1989 Nov; 32(11):2426-31. PubMed ID: 2810330
[TBL] [Abstract][Full Text] [Related]
36. Novel synthesis and in vitro characterization of disulfide-linked ricin-monoclonal antibody conjugates devoid of galactose binding activity.
Pietersz GA; Kanellos J; McKenzie IF
Cancer Res; 1988 Aug; 48(16):4469-76. PubMed ID: 3260814
[TBL] [Abstract][Full Text] [Related]
37. Antitumor activity of adriamycin (hydrazone-linked) immunoconjugates compared with free adriamycin and specificity of tumor cell killing.
Braslawsky GR; Edson MA; Pearce W; Kaneko T; Greenfield RS
Cancer Res; 1990 Oct; 50(20):6608-14. PubMed ID: 2208123
[TBL] [Abstract][Full Text] [Related]
38. Vinblastine-C4 alkyl maleoyl and amino acid maleoyl derivatives. II. Experimental antitumor activity against leukemias and human tumor xenografts.
Collard MP; Rao KS; Trouet A
Anticancer Res; 1989; 9(3):625-30. PubMed ID: 2764509
[TBL] [Abstract][Full Text] [Related]
39. Preparation, phototoxicity and biodistribution studies of anti-carcinoembryonic antigen monoclonal antibody-phthalocyanine conjugates.
Carcenac M; Larroque C; Langlois R; van Lier JE; Artus JC; Pèlegrin A
Photochem Photobiol; 1999 Dec; 70(6):930-6. PubMed ID: 10628305
[TBL] [Abstract][Full Text] [Related]
40. Anti-tumour activity of aminopterin-monoclonal antibody conjugates; in vitro and in vivo comparison with methotrexate-monoclonal antibody conjugates.
Kanellos J; Pietersz GA; Cunningham Z; McKenzie IF
Immunol Cell Biol; 1987 Dec; 65 ( Pt 6)():483-93. PubMed ID: 3502340
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
